Insight Molecular Diagnostics Inc.
General ticker "IMDX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $149.6M (TTM average)
Insight Molecular Diagnostics Inc. follows the US Stock Market performance with the rate: 37.4%.
Estimated limits based on current volatility of 2.8%: low 4.41$, high 4.69$
Factors to consider:
- Earnings expected soon, date: 2026-08-10 bmo
- Total employees count: 58 (+18.4%) as of 2025
- Top business risk factors: Reliance on few tests, Equipment/reagent issues, Market competition, Regulatory and compliance, Cybersecurity threats
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.64$, 10.89$]
- 2026-12-31 to 2027-12-31 estimated range: [2.68$, 8.26$]
Financial Metrics affecting the IMDX estimates:
- Negative: with PPE of -5.4 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -11.50 <= 0.30
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0.06 <= 0.75
- Negative: negative Industry operating cash flow (median)
- Negative: Investing cash flow per share per price, % of -1.65 <= -0.65
- Negative: -0.15 < Industry inventory ratio change (median), % of 0
Short-term IMDX quotes
Long-term IMDX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1.50MM | $1.71MM | $4.05MM |
| Operating Expenses | $26.64MM | $62.75MM | $55.18MM |
| Operating Income | $-25.14MM | $-61.04MM | $-51.12MM |
| Non-Operating Income | $0.28MM | $0.38MM | $0.90MM |
| Interest Expense | $0.05MM | $0.08MM | $0.11MM |
| R&D Expense | $9.29MM | $9.84MM | $15.90MM |
| Income(Loss) | $-24.86MM | $-60.66MM | $-50.22MM |
| Other Income(Loss) | $-2.93MM | $0.00MM | $0.00MM |
| Net Income(Loss)* | $-27.78MM | $-60.66MM | $-50.22MM |
| Stockholders Equity | $20.47MM | $-12.27MM | $-31.46MM |
| Inventory | $0.00MM | $0.41MM | $0.45MM |
| Assets | $74.89MM | $35.08MM | $25.76MM |
| Operating Cash Flow | $-23.32MM | $-20.71MM | $-22.18MM |
| Capital expenditure | $0.28MM | $0.52MM | $3.19MM |
| Investing Cash Flow | $-0.93MM | $-0.51MM | $-3.19MM |
| Financing Cash Flow | $12.19MM | $20.43MM | $28.07MM |
| Earnings Per Share** | $-3.63 | $-4.64 | $-1.65 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.